chrisvoncsefalvay/vaers-outcomes huggingface dataset:
caller received the 1st dose on 04Mar2021 and the 2nd dose on 24Jun2021; stomachache; felt a little weird/felt much less funny than 1st dose, for 1h30; minimal dizziness; she had a slight fever last night; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (caller received the 1st dose on 04Mar2021 and the 2nd dose on 24Jun2021), ABDOMINAL PAIN UPPER (stomachache), FEELING ABNORMAL (felt a little weird/felt much less funny than 1st dose, for 1h30), DIZZINESS (minimal dizziness) and PYREXIA (she had a slight fever last night) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048C21A and 023M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, ATORVASTATIN and OMEPRAZOLE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (caller received the 1st dose on 04Mar2021 and the 2nd dose on 24Jun2021), ABDOMINAL PAIN UPPER (stomachache), FEELING ABNORMAL (felt a little weird/felt much less funny than 1st dose, for 1h30), DIZZINESS (minimal dizziness) and PYREXIA (she had a slight fever last night). On 24-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (caller received the 1st dose on 04Mar2021 and the 2nd dose on 24Jun2021), ABDOMINAL PAIN UPPER (stomachache), FEELING ABNORMAL (felt a little weird/felt much less funny than 1st dose, for 1h30), DIZZINESS (minimal dizziness) and PYREXIA (she had a slight fever last night) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-237397 (Patient Link).
Info has been received from a licensed practical nurse concerning an elderly female who "early in November 2002" was vaccinated in the deltoid with a dose of pneumococcal vaccine 23 polyvalent (Lot #643251/0445M) (it is unknown if first dose). Subsequently, the pt developed redness and induration from her elbow to her shoulder. The pt was seen at an ER, but not treated and sent home with instructions to apply cold compresses. Follow up info received from a licensed practical nurse indicated that she was "unable to locate" the elderly woman. It was noted that the pt was seen in the ER and treated for cellulitis. No further info is available due to the inability of the reporter to contact the pt and obtain a release. The reporter indicated that 9 other pts were vaccinated with a dose of pneumococcal vaccine 23 polyvalent (Lot #643251/0445M) and developed induration at the injection site (WAES #0212USA00825, 0212USA01192, 0212USA01193, 0304USA02075, 0304USA02076, 0304USA02077, 0304USA02078, 0304USA02079 and 0304USA02081). No further info is expected.
Pt recvd vax on 11JUN92 & found to have antibodies directed against the Hep B surface antigen, & Hep C antibodies; No further details were provided;
Information has been received from a registered nurse concerning a female child who on an unspecified date was vaccinated with the second dose of varicella vaccine. Subsequently, the pt develpoed a generalized rash and sought medical attention. It was also reported that the child's mother was inadvertently splashed on the hand with varicella vaccine and developed a localized blistery rash. Additional info has been requested.
Body aches, headache, shaking chills and fever (102.6). Treated with Tylenol, rest and fluids. Symptoms lasted 60 hours.
Conceived 1 week after second dosage, had a miscarriage around 8 weeks pregnant
Felt fine all day after shot, other than sore arm at injection site until about 5 p.m., a good 7 hours after shot.  Got light headed to the point of nearly fainting, violent feverish chills and nauseousness.  24 hours later, still dealing with heavy feverish sweating and nauseousness.  Not concerned, but wanted to note it for your records.  Info sent home with me noted 1 in 6 patients will see such a reaction, so simply assume I'm one of them.
Patient was giving a Moderna .25ml.  Later it was discovered that the MOderna Vial had expired, due to Time Out.
Pt exp pox,pharyngitis,buccal,lingual ulcerations & T101.2
Immediately after shot was given I went into a haze where I didn?t know where I was or who was around me. I heard voices but I was staring off into space, a rash started and i was shaking. I started sweating, body aches, my arm went numb down to my fingers starting with tingling sharp pain, my heart rate was racing and it felt like an elephant on my chest to breathe. Nurses were talking to me and using ice packs per my request as I was talking to them but not able to remember who I talked to or what I had told them previously. They wanted to call an ambulance but I took all the antihistamines I had and they kept observing until I proved I could walk and go home. I went home and called my immunologist and he had me check in. Symptoms lingered for weeks. Arm pain resolved after 3 months. Headaches continued to be sharp on left side of head for those 3 months as well. I only know all symptoms of  what happened as the nurses told me when I was leaving because I was so zoned out.  I also was in the observation (make shift hospital room) for the vaccine the whole time and laying on the bed not sitting in a chair with others in whole site.
Get sick after getting the second shot; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Get sick after getting the second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Get sick after getting the second shot). At the time of the report, ILLNESS (Get sick after getting the second shot) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable   Reporter did not allow further contact
She stated she was "woozy" immediately after shot. She slumped over and started snoring as I was applying her band-aid. I talked to her and she awoke very quickly (less than 1 minute later). She waited for a while (15 mins) then left. She refused ambulance so I called her same afternoon and she was feeling fine.
Pharmacist discovered vaccine product (Pfizer) had extra doses /solution then what he has normally come accustomed to into later part of working shift when recording/drawing  a 6th and final dose to be administered of Pfizer vaccine. Pharmacist believes there were 1-2 more doses at least left worth remaining to able to be given from product. Video footage has not been studied nor possibly will not be able to reviewed or confirm but am taking precautions in case vaccine product did not have "extra" doses and patient was inadvertently  given wrong vaccine (Moderna) as booster and or overly diluted product. Incident reporting was delayed due to ideally wanting  this all confirmed with visual footage however have decided to take extra over precaution.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered after vial being punctured and left at room temperature for almost 23 hours) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered after vial being punctured and left at room temperature for almost 23 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered after vial being punctured and left at room temperature for almost 23 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided by the reporter. It was reported that the vial was initially stored in refrigerator on 28-Jan-2022 and the vial was first punctured on 13-Feb-2022 at 11:11 AM. The vial was punctured and then left at room temperature range (8 Degree Celsius to 25 Degree Celsius) for about 23 hours. Patient was administered with the vaccine on 14-Feb-2022. The vial did not undergo any temperature excursions. Reporter stated that they gave the patient two doses at their facility but was not sure if this is their booster or second dose.  No treatment medication was provided by the reporter.
Nausea and light headed on Feb 7, day of shot. Light headache and more severe muscle and join pain on Feb 8.
Developed initial lesion on face on 1/27.  No fever but has had development of ongoing varicellaform lesions over entire body, some starting to crust at 48 hours.
Body Ache, Headache, Sore Arm, Chills, Nausea, Vomit, Fever Blisters in my mouth.
History -> seen for 4 month check up. Happy, smiling. Had otitis that had not cleared, afebrile. Gave immunizations, 2 hours later became very irritable with crying, then developed fever later in the afternoon. Fever only documented by touch of mother. Seen next day because of history of fever, irrit. Admitted for ROS WBC increased 21,000 fever gone by time of admit - D/C next day.
ON THE EVENING OF THE VACCINATION, EYES BEGAN TO TWITCH AND BLINK OUT OF HER CONTROL; THIS HAS CONTINUED STILL AND HAS NOT EVEN BEEN TREATABLE WITH BOTOX, WHICH IS THTE NORMAL TREATMENT FOR WHAT DOCTORS HAVE DIAGNOSED HER WITH - BLEPHARSPASM.
Information was received from a medical assistant regarding an unspecified number of patients (demographics not provided). On an unknown date, an unspecified amount of doses of GARDASIL (route of administration not provided) that underwent temperature excursions were administered to an unspecified amount of patients. No adverse effect reported. No further information was provided. This is one of several reports from the same reporter. Additional information has been requested.
fever, redness and swelling and itch at injection site, trouble breathing, tired, felt like I had covid again, insomnia, itchy through out body, headache, chills
Mild fever and fatigue about an hour after the vaccine Itchy rash developed on the arm around the injection site over the next two days. (Benedryl and calamine worked a ton on the rash)
6 X 9 cm, area of erythema with induration on right thigh lateral thigh
Information has been received from a physician concerning a male who on 04-APR-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck). In March 2009 while the patient was on vacations he developed shingles. The patient had pain that was diagnosed as "ophthalmic division of the 5th cranial nerve". He had pain from his left ear to his temple and scalp with numbness of his left eyebrow. The physician said he had severe postherpetic neuralgia. The patient was hospitalized twice and treated with VALTREX and VICODIN. The patient sought unspecified medical attention. The patient had not recovered. Additional information has been requested.  Follow up information was received from a physician who reported the 76 year old patient was vaccinated on the left side with a 0.5 cc dose of ZOSTAVAX (Merck) (lot # 659267/1836U). The patient has a history of chicken pox. It was unknown if the patient had recently been exposed to chicken pox or herpes zoster. The patient went to the emergency room at a hospital on 08-MAR-2009 and 09-MAR-2009 but was not admitted. The patient was seen by an ophthalmologist at an eye center on 10-MAR-2009. The physician saw the patient in the office on 26-MAR-2009. The physician stated that the left 5th cranial nerve-ocular branch was healed when he saw the patient. The lesions had healed but the neuralgia still persisted. He indicated that the patient experienced pain reaching from the left ear to the temple to the scalp. The physician stated that he kept the patient on VALTREX and instructed the patient to come back in 1 month. The physician indicated that his concern involved the potentially lifelong pain that the patient could experience as a result of the postherpetic neuralgia. Follow up information was received from the physician concerning the 77 year old (previously reported as 76 year old, also reported as 78 year old) retired patient with atrial fibrillation (A. FIB), prostate cancer, coronary atherosclerosis, hypertension, and diabetes type II who was subcutaneously vaccinated with the first dose of ZOSTAVAX (Merck) on 04-APR-2009. In AM on 08-MAR-2009, the patient developed clinical shingles involving left 5th cranial nerve distribution and was evaluated in the Emergency room at a hospital. He had persistent post herpetic neuralgia. Additional information is not expected.
Phone call from pt on 2/14/02, stating that on 2/7/02, he began experiencing visual problems with double vision and went to the hospital. He was admitted and had a CT Scan. Dx was questionable nerve damage to the left eye. Has an appt for MRI.
Experienced pretty severe symptoms the two days following vaccine. Exposed to Covid on May 7 and tested positive on May 12. Was prescribed Paxlovid for symptoms.
DEVELOPMENT OF TINNITUS (MODERATE) WITHIN 1 WEEK OF VACCINNATION DATE.
About 7 hours after receiving the vaccination I had severe chills with shivering and could not get warm.   I did not need medical attention and was fine within 2 hours.
Became dizzy, headache, felt like she was going to faint, rigors and a temperature of 101.5.  Next morning she had upset stomach, feeling dizzy, thought she was going to faint and a headache.
So, on the 17th I noticed I had excessive thirst. I went to my dad's house, and I had 64 ounces of water. I thought I was having blood clots again. I went to the ER, and they diagnosed me with Diabetic Ketosis Acidosis. My blood sugar was in the 400s. I went to the doctors, and they diagnosed me with diabetes. I have changed my diet and I am on insulin. I also took metformin for 6 months. The unexplained diabetes after diet change. I also got the booster, and my glucose levels went up again.
Headache, low grade fever 100.5 - 101, body aches,  soreness at injection site (lasting 1 day)  Swollen lymph node under arm of injection site - started day of vaccine and still present 4 days later
pt recvd vax 19NOV03 & became pale-limp p/left clinic; pt brought to clinic again assessment VS done; refer red pt to hosp ER for evual
Pt received vaccine that was stored improperly. Vaccine was moved from ultra-cold freezer to freezer on 6/17/21. According to Pfizer, vaccine stored in the freezer after day 17 is considered improperly stored, and the pt will need to be re-vaccinated.
Started with aching in joints. Trembling almost uncontrollably... spiked a fever...highest that I know of 103.6. Extremely fatigued. A little SOB.  Felt very dizzy. So weak..sick I couldn't get up to get medication for fever, to use bathroom, or anything. Not sure if eventually fell asleep or loss consciousness. Woke up roughly 26 -27 hours later. Was disoriented when first woke up. Felt very "sickly", weak, had urinated on myself.  Got up, cleaned myself, temp was100.8, took Tylenol and drank water. Laid back down. 24 hours later felt some better. Temp was gone. I literally felt like I was going to die when my temp was so high prior to falling asleep or losing consciousness.
Pt. developed swelling, the size of 1/2 orange, at injection site, with area of redness and warmth down to elbow, which lasted about 3 days.
Breakthrough COVID-19 case with unknown symptom onset date:  Abdominal pain. Hospitalized 8/28/2021-8/31/2021. Admission Diagnoses: Acute Abdominal Pain, UTI, Pneumonia of both lungs due to infectious organism, CKD, COVID-19 virus infection. Discharge Diagnoses: Acute cystitis without hematuria due to Candida, Vaccinated COVID-19 infection with early pneumonia, Dehydration, CKD stage III, Metastatic prostate cancer undergoing therapy, Type 2 diabetes well controlled on insulin, essential hypertension, gallstones and sludge without evidence of cholecystitis
Patient received Moderna booster 0.25 vaccine on 12/08/2021. Patient stated that she started feeling dizzy the next morning, before falling and hitting her head on the corner of the bed. Patient was taken to Hospital. Patient stated that she had a  CT was done and  and showed sings of possible stroke. Patient also informed me that she  was then  transported to another Hospital where she was admitted and had a MRI done. Patient informed me that MRI was normal and she was released on Sunday.
The day after the vaccine patient started to have what she thought were a couple of bug bites. Then 2 days later the bumps had spread throughout her entire body. She had blisters/rash from her hands arms trunk to her toes.
Entire body feeling hot; Face flushing; Increased heart rate; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 13Apr2021 at 17:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), probiotics (unspecifed) and AREDS 2; all for unknown indications, from unknown date and unknown if ongoing. On 13Apr2021 at 18:00, the patient experienced entire body feeling hot, face flushing and increased heart rate. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events entire body feeling hot, face flushing and increased heart rate were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
R sided painful blistered rash; Blistered rash; This case was reported by a other health professional via interactive digital media and described the occurrence of painful rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2020, the patient received Shingrix. In November 2020, less than a week after receiving Shingrix, the patient experienced painful rash and blistery rash. On an unknown date, the outcome of the painful rash and blistery rash were unknown.   It was unknown if the reporter considered the painful rash and blistery rash to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. A week before the date of reporting, the patient received Shingrix. The patient called to the reporter and told that the patient had right sided painful blistered rash. No further information was provided.
Headache, Myalgia, Muscle ache, Soreness at injection site Narrative:
Pt in office 08/08/2005 for well exam and MMR, varicella, Prevnar given. Developed rash about 4" later with some wheezing and was taken to ER. No wheezing heard by the time of ER. Had erythematous, slightly raised rash over most of body. Benadryl 5ml 1m and breathing Treatment given. Improved after 1 hour of monitoring. Started on Prelone and discontinue home. In process of referring to Allergist.
My neighbor and she told me they have another family member in the chair they experience the same problem from walking. She had only one vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).This consumer reported for a patient (caller neighbour family member).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GAIT DISTURBANCE (non-serious) with onset 2021, outcome "unknown", described as "My neighbor and she told me they have another family member in the chair they experience the same problem from walking. She had only one vaccine".  Additional Information: caller neighbour and she told me they have another family member in the chair they experience the same problem from walking. She had only one vaccine. She was complaining about this. (Further information unknown)  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Diffuse small papular red erythematous rash. Bilateral proximal thighs. Benadryl
States developed left deltoid redness, swelling and itching about 24 hours after event.
patients administered Moderna vaccine while temperature excursion assessment was ongoing; patients administered Moderna vaccine while temperature excursion assessment was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients administered Moderna vaccine while temperature excursion assessment was ongoing) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients administered Moderna vaccine while temperature excursion assessment was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients administered Moderna vaccine while temperature excursion assessment was ongoing) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Reporter confirmed that patients had been administered doses while the temperature excursion assessment has been ongoing. No treatment medications were reported.
Pt recv vax on 3/16/99; on 3/28/99 pt exp rash on face, stomach, arms w/ itching